Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Gw Pharma ADR (GWPH)

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,014,131
  • Shares Outstanding, K 30,162
  • Annual Sales, $ 12,730 K
  • Annual Income, $ -295,160 K
  • 60-Month Beta 2.32
  • Price/Sales 397.03
  • Price/Cash Flow N/A
  • Price/Book 7.90

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.13
  • Number of Estimates 8
  • High Estimate 1.68
  • Low Estimate -1.80
  • Prior Year -1.26
  • Growth Rate Est. (year over year) +89.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
161.52 +0.98%
on 07/17/19
180.75 -9.76%
on 07/10/19
-7.22 (-4.24%)
since 06/17/19
3-Month
151.32 +7.78%
on 04/18/19
196.00 -16.79%
on 05/07/19
+7.36 (+4.73%)
since 04/17/19
52-Week
90.14 +80.94%
on 12/27/18
196.00 -16.79%
on 05/07/19
+16.74 (+11.44%)
since 07/17/18

Most Recent Stories

More News
With 10,000 Licenses Issued, California Reflects the Growing Power of Hemp

As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state's thriving industry.

CRON : 14.99 (+0.33%)
WEED.TO : 47.69 (+2.43%)
GWPRF : 13.3800 (-3.18%)
CRON.TO : 19.61 (+0.20%)
GWPH : 163.00 (-1.95%)
TGOD.TO : 3.28 (+2.18%)
SGMD : 0.0159 (+6.71%)
CGC : 36.59 (+2.90%)
TGODF : 2.5180 (+3.20%)
Scott's Miracle Grow's, ADT, Innovative Industrial Properties and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day

Scott's Miracle Grow's, ADT, Innovative Industrial Properties and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day

IIPR : 125.68 (-2.17%)
ADT : 6.21 (-3.72%)
GWPH : 163.00 (-1.95%)
SMG : 102.91 (-0.62%)
Is GW Pharmaceuticals (GWPH) Outperforming Other Medical Stocks This Year?

Is (GWPH) Outperforming Other Medical Stocks This Year?

GWPH : 163.00 (-1.95%)
Cronos to Acquire Apotex's Manufacturing Plant in Winnipeg

Cronos (CRON) inks deal to acquire fermentation and manufacturing facility in Winnipeg, Canada, from Apotex Fermentation Inc.

CRON : 14.99 (+0.33%)
GWPH : 163.00 (-1.95%)
CTST : 2.86 (+4.00%)
CGC : 36.59 (+2.90%)
GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know

GW Pharmaceuticals PLC (GWPH) closed at $172.45 in the latest trading session, marking a -1.25% move from the prior day.

GWPH : 163.00 (-1.95%)
Legal Cannabis Faces Competition from Black Market: 3 Stocks That Can Lead the Brigade

The recent legalization of marijuana in several states in the US has had many people eager to invest in the emerging sector.

IIPR : 125.68 (-2.17%)
GWPH : 163.00 (-1.95%)
SMG : 102.91 (-0.62%)
CannTrust Falls as Health Canada Issues Non-Compliance Report

Health Canada issues a non-compliance report on CannTrust (CTST) regarding its greenhouse facility in Pelham, Ontario, which is used for growing cannabis. Shares take a hit.

CRON : 14.99 (+0.33%)
GWPH : 163.00 (-1.95%)
CTST : 2.86 (+4.00%)
CGC : 36.59 (+2.90%)
The Zacks Analyst Blog Highlights: GW, Scotts Miracle-Gro, Cronos, CannTrust and Canopy

The Zacks Analyst Blog Highlights: GW, Scotts Miracle-Gro, Cronos, CannTrust and Canopy

CRON : 14.99 (+0.33%)
GWPH : 163.00 (-1.95%)
SMG : 102.91 (-0.62%)
CTST : 2.86 (+4.00%)
CGC : 36.59 (+2.90%)
The Must-Know Cannabis Stocks Before Vapes Hit Canadian Shelves in December 2019

Consumer buying habits are shifting, as the cannabis industry evolves. As that happens, investors are being offered incredible opportunities. For example, according to GMP Securities, "demand for extracted...

ACB : 7.41 (+3.49%)
ACB.TO : 9.68 (+3.31%)
ACBFF : 8.6900 (-12.80%)
APHA : 6.56 (+4.13%)
GWPH : 163.00 (-1.95%)
NEPT.TO : 6.38 (+1.75%)
APHA.TO : 8.59 (+4.00%)
TGOD.TO : 3.28 (+2.18%)
VAPN.CN : 1.800 (unch)
TGODF : 2.5180 (+3.20%)
NEPT : 4.89 (+1.45%)
5 Picks Ahead of Key Congressional Hearing on Marijuana Laws

Several economists and market researchers believe that the four bills may pave the way for marijuana ETFs, which are likely to attract billions of dollars in investment.

CRON : 14.99 (+0.33%)
GWPH : 163.00 (-1.95%)
SMG : 102.91 (-0.62%)
CTST : 2.86 (+4.00%)
CGC : 36.59 (+2.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade GWPH with:

Business Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and...

See More

Key Turning Points

2nd Resistance Point 170.04
1st Resistance Point 168.14
Last Price 163.00
1st Support Level 164.92
2nd Support Level 163.60

See More

52-Week High 196.00
Last Price 163.00
Fibonacci 61.8% 155.56
Fibonacci 50% 143.07
Fibonacci 38.2% 130.58
52-Week Low 90.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar